0,872  0,007  Antiinflammatory
0,864  0,003  Cholesterol antagonist
0,863  0,009  Apoptosis agonist
0,851  0,005  Antihypercholesterolemic
0,833  0,004  Bone diseases treatment
0,829  0,008  CYP3A4 substrate
0,804  0,004  Antiosteoporotic
0,778  0,008  Carcinogenic
0,743  0,005  Nitric oxide antagonist
0,750  0,016  Transcription factor NF kappa B inhibitor
0,738  0,008  Chemopreventive
0,724  0,005  Antipsoriatic
0,638  0,009  NOS3 expression inhibitor
0,637  0,009  Proliferative diseases treatment
0,619  0,022  Teratogen
0,606  0,012  Immunosuppressant
0,592  0,012  Hepatic disorders treatment
0,591  0,011  Caspase 3 stimulant
0,593  0,026  TNF expression inhibitor
0,567  0,002  Pregnane X receptor agonist
0,581  0,027  Antileukemic
0,556  0,013  Antifungal
0,557  0,017  Antineoplastic (cervical cancer)
0,551  0,010  Cardiotonic
0,575  0,039  Antineoplastic (breast cancer)
0,549  0,021  Antineoplastic (ovarian cancer)
0,533  0,014  Antihypertensive
0,517  0,010  Heart failure treatment
0,538  0,031  Antibacterial
0,527  0,021  Cytotoxic
0,511  0,005  Antiparkinsonian, rigidity relieving
0,520  0,016  NOS2 expression inhibitor
0,522  0,029  Embryotoxic
0,502  0,020  Lipoprotein disorders treatment
0,503  0,023  Immunomodulator
0,473  0,005  Sodium/bile acid cotransporter inhibitor
0,478  0,014  UGT2B4 substrate
0,471  0,007  Interferon gamma antagonist
0,463  0,004  Antipruritic, non-allergic
0,461  0,007  UGT2B7 substrate
0,468  0,017  Antineoplastic (lymphoma)
0,466  0,015  Hypolipemic
0,448  0,009  Contraceptive
0,463  0,024  Metabolic disease treatment
0,450  0,013  UGT1A1 substrate
0,444  0,012  P-glycoprotein inhibitor
0,438  0,008  Prostate disorders treatment
0,471  0,042  Antipruritic, allergic
0,428  0,012  UGT1A4 substrate
0,440  0,030  Antineoplastic (brain cancer)
0,449  0,041  Prostate cancer treatment
0,437  0,030  Antineoplastic (glioma)
0,458  0,052  Antineoplastic (lung cancer)
0,410  0,005  Antihyperlipoproteinemic
0,407  0,004  UGT2B9 substrate
0,463  0,062  Antidiabetic
0,463  0,062  Cyclophilin D inhibitor
0,430  0,032  Antineoplastic (pancreatic cancer)
0,414  0,029  Antidiabetic (type 2)
0,408  0,023  UGT1A6 substrate
0,379  0,005  Interleukin 4 antagonist
0,385  0,013  Prostatic (benign) hyperplasia treatment
0,404  0,034  Antioxidant
0,380  0,013  Antiacne
0,370  0,006  Cholesterol synthesis inhibitor
0,401  0,044  Respiratory analeptic
0,364  0,008  DNA polymerase I inhibitor
0,363  0,017  Hepatoprotectant
0,357  0,013  Lipocortins synthesis antagonist
0,430  0,089  Antineoplastic (solid tumors)
0,386  0,046  ICAM1 expression inhibitor
0,344  0,012  Antiviral (Influenza A)
0,341  0,010  Acute respiratory distress syndrome (ARDS) treatment
0,385  0,054  Immunostimulant
0,353  0,025  Abortion inducer
0,361  0,033  Antineoplastic (renal cancer)
0,390  0,070  Atherosclerosis treatment
0,323  0,007  UGT2B1 substrate
0,331  0,017  UGT1A3 substrate
0,331  0,017  Anesthetic
0,314  0,005  Farnesoid X receptor antagonist
0,336  0,028  Antineoplastic (sarcoma)
0,375  0,071  CYP2C9 substrate
0,312  0,009  Antineoplastic antibiotic
0,307  0,008  Neurotrophic factor
0,323  0,025  Antiviral (Influenza)
0,322  0,029  Anesthetic general
0,318  0,032  UDP-glucuronosyltransferase substrate
0,304  0,019  Hair growth stimulant
0,363  0,081  Antiobesity
0,339  0,061  AR expression inhibitor
0,279  0,003  Hyperparathyroidism treatment
0,315  0,045  Antineoplastic (liver cancer)
0,321  0,052  Antineoplastic (endocrine cancer)
0,278  0,026  Diuretic
0,313  0,068  Analeptic
0,298  0,056  Sensitization
0,304  0,065  CYP2C19 substrate
0,289  0,051  Antineoplastic (glioblastoma multiforme)
0,314  0,077  Apoptosis antagonist
0,301  0,073  Interleukin 2 agonist
0,250  0,026  Skin whitener
0,224  0,004  Liver X receptor alpha agonist
0,229  0,011  Androgen antagonist
0,228  0,013  Arachidonic acid antagonist
0,274  0,061  Vascular (periferal) disease treatment
0,264  0,055  Antimitotic
0,209  0,004  Hypercalcemia treatment
0,211  0,007  Interleukin 2 antagonist
0,266  0,063  Angiogenesis stimulant
0,348  0,147  Caspase 9 stimulant
0,203  0,004  Liver X receptor agonist
0,229  0,033  Liver fibrosis treatment
0,243  0,047  Antihelmintic
0,218  0,026  Antifungal enhancer
0,195  0,007  Vanilloid agonist
0,200  0,014  Antiinfertility, female
0,188  0,003  Na+ K+ transporting ATPase inhibitor
0,217  0,032  Toxic, respiratory center
0,211  0,026  Protein-tyrosine phosphatase 1B inhibitor
0,211  0,029  UGT2B10 substrate
0,185  0,006  Anabolic
0,271  0,093  Antineoplastic (colorectal cancer)
0,215  0,037  UGT2B15 substrate
0,182  0,004  Anticholelithogenic
0,197  0,020  Microtubule formation inhibitor
0,208  0,034  Bone formation stimulant
0,184  0,010  Inducible nitric-oxide synthase inhibitor
0,261  0,090  Antineoplastic (colon cancer)
0,238  0,066  Antiparasitic
0,266  0,095  CTGF expression inhibitor
0,183  0,020  Alcohol dehydrogenase substrate
0,206  0,044  Protein-tyrosine phosphatase inhibitor
0,168  0,009  Paget's disease treatment
0,168  0,009  UGT2B11 substrate
0,228  0,079  Free radical scavenger
0,165  0,016  Actinic keratosis treatment
0,190  0,045  Protein kinase stimulant
0,238  0,094  Chemoprotective
0,164  0,027  Choleretic
0,144  0,014  CDC25A inhibitor
0,157  0,029  Contraceptive female
0,176  0,049  Antidiarrheal
0,224  0,099  Interleukin agonist
0,164  0,042  Antifungal (Cryptococcus)
0,203  0,083  Antineoplastic enhancer
0,138  0,017  Contraceptive male
0,196  0,080  Neurotrophic factor enhancer
0,134  0,022  ABCA1 expression enhancer
0,113  0,003  Vitamin D receptor antagonist
0,288  0,178  Alzheimer's disease treatment
0,117  0,009  5-Alpha-reductase inhibitor
0,110  0,003  Parathyroid hormone antagonist
0,157  0,052  Adenylate cyclase stimulant
0,139  0,035  Anticataract
0,114  0,015  Estrogen agonist
0,110  0,016  Antiviral (RSV)
0,187  0,093  Antihypertriglyceridemic
0,109  0,016  Glycine receptor agonist
0,140  0,056  Antihemorrhagic
0,125  0,041  Sulfotransferase substrate
0,116  0,033  SULT1E1 substrate
0,094  0,012  Estrogen receptor beta agonist
0,138  0,059  Cyclooxygenase 3 inhibitor
0,083  0,004  Microtubule stabilization
0,088  0,010  Estrogen receptor alpha agonist
0,123  0,049  Estrogen antagonist
0,113  0,040  Antineoplastic alkaloid
0,117  0,047  Toll-Like receptor 4 antagonist
0,077  0,008  RNA-directed RNA polymerase stimulant
0,081  0,013  Lipocortins synthesis agonist
0,104  0,040  Bile acid receptor antagonist
0,097  0,036  Antibiotic
0,098  0,040  Transcription factor NF kappa B stimulant
0,155  0,097  Phospholipase C inhibitor
0,122  0,067  Growth stimulant
0,069  0,015  Opioid kappa receptor agonist
0,073  0,019  Postcoital contraceptive
0,063  0,009  Farnesoid X receptor agonist
0,087  0,037  SULT1A2 substrate
0,051  0,003  Vitamin D receptor agonist
0,104  0,057  Estrogen receptor beta antagonist
0,136  0,090  Antiviral (Herpes)
0,051  0,005  CYP24 inhibitor
0,179  0,135  Hypoglycemic
0,070  0,026  Postmenopausal disorders treatment
0,052  0,010  Glucose-6-phosphate dehydrogenase inhibitor
0,148  0,108  Platelet adhesion inhibitor
0,048  0,008  HMG CoA reductase inhibitor
0,148  0,109  Diabetic nephropathy treatment
0,154  0,117  Antirickettsial
0,185  0,151  UGT1A9 substrate
0,085  0,051  Opioid kappa receptor antagonist
0,133  0,100  Hexokinase inhibitor
0,065  0,035  Heme oxygenase stimulant
0,065  0,035  Androgen agonist
0,036  0,006  Hedgehog signaling activator
0,077  0,049  Antitreponemal
0,118  0,091  Liver cirrhosis treatment
0,043  0,021  Cholesterol absorption inhibitor
0,032  0,010  1,3-Beta-glucan synthase inhibitor
0,186  0,165  Antimycobacterial
0,064  0,045  CDC25B inhibitor
0,131  0,113  Melanin inhibitor
0,061  0,044  Antimycoplasmal
0,017  0,001  Vitamin D-like
0,089  0,073  Lanosterol 14 alpha demethylase inhibitor
0,036  0,020  Tubulin agonist
0,026  0,011  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,067  0,053  SULT2A1 substrate
0,097  0,084  SULT1A1 substrate
0,122  0,112  NOS3 expression enhancer
0,022  0,013  Corticosteroid-like
0,021  0,012  5-Alpha-reductase 2 inhibitor
0,014  0,006  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,069  0,069  Narcotic antagonist

